Jean-Pierre Gotteland
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Jean-Pierre Gotteland
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
23
| Public Company | Pharmaceuticals: Major | 23 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.
10
| Extinct | Pharmaceuticals: Major | 10 |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland.
6
| Extinct | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jean-Pierre Gotteland via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
| University of Zurich | College/University | Doctorate Degree Doctorate Degree | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Founder | |
| University of Geneva | College/University | Graduate Degree Doctorate Degree | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Investment Committee Member | |
| IPSEN | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree Undergraduate Degree | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Centro de Estudios Financieros | College/University | Masters Business Admin | |
Tres Cantos Open Lab Foundation
 Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Miscellaneous Commercial Services | Director/Board Member | |
MaxiVAX SA
 MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Miscellaneous Commercial Services | Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chairman | |
| University of Fribourg | College/University | Undergraduate Degree | |
Sofinnova Crossover Fund
 Sofinnova Crossover Fund Financial ConglomeratesFinance Sofinnova Crossover Fund provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
Mundipharma, Inc.
 Mundipharma, Inc. Pharmaceuticals: MajorHealth Technology Mundipharma, Inc. manufactures and markets pharmaceutical products. The company is located in Albany, NY. | Pharmaceuticals: Major | Director/Board Member | |
Metriopharm AG
 Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Imperial College London | College/University | Doctorate Degree | |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
| Hotel Bookings International Ltd. | Director/Board Member | ||
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
Ava AG
 Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Chairman | |
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology CDR-Life Inc. is a Swiss biotherapeutics company that develops novel immunotherapies to target the power of the immune system specifically to tumor cells. CDR-Life is based in Schlieren, Switzerland, and was founded in 2017 by Leonardo Borras, Christian Leisner, Dominik Escher, Rouven Bingel-Erlenmeyer, and Konstantin von Schulthess. The company's proprietary antibody platform targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high affinity and specificity, which allows them to develop a pipeline of first-in-class therapeutics across a broad range of solid tumors. The company is backed by leading cross-Atlantic investors and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat macular degeneration. Christian Leisner has been the CEO since 2017. | Biotechnology | Director/Board Member | |
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Innoskel SASU
 Innoskel SASU BiotechnologyHealth Technology Innoskel SASU is a French bioscience platform company that aims to improve the quality of life of patients with severe rare bone disorders. Innoskel is based in Valbonne, France, and was founded by Elvire Gouze, who has been the CEO since incorporation. The company achieves this goal through patient centricity, scientific innovation, and operational excellence. Innoskel is developing transformative therapies for the unmet needs of individuals with rare bone disorders, with a focus on type II collagen disorders. The company's lead asset is INS-101, a gene therapy that has shown strong efficacy in preclinical studies. | Biotechnology | Chairman | |
| Jeito Capital | Chief Executive Officer | ||
Women Innovating Together In Healthcare
 Women Innovating Together In Healthcare Miscellaneous Commercial ServicesCommercial Services Women Innovating Together In Healthcare operates as an organization of accomplished women. The private company is based in Paris, France. The French company was founded by Rafaèle Elisabeth Tordjman. | Miscellaneous Commercial Services | Founder |
Statistieken
Internationaal
| Zwitserland | 17 |
| Verenigde Staten | 12 |
| Frankrijk | 11 |
| Verenigd Koninkrijk | 10 |
| Denemarken | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Finance | 5 |
| Distribution Services | 2 |
Operationeel
| Director/Board Member | 243 |
| Corporate Officer/Principal | 85 |
| Independent Dir/Board Member | 83 |
| Director of Finance/CFO | 36 |
| Chairman | 30 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Ed Mathers Mathers | 47 |
| Michèle Ollier | 33 |
| Leonard Patrick Gage | 26 |
| Allan Shaw | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Anne VanLent | 23 |
| Jacques Theurillat | 22 |
| Barbara Duncan | 22 |
| Brian O'Callaghan | 20 |
| Tim Adams | 17 |
| Frank Verwiel | 16 |
| Elizabeth Garner | 15 |
| Mario Corso | 10 |
| Kathryn L. Biberstein | 9 |
- Beurs
- Insiders
- Jean-Pierre Gotteland
- Bedrijfsconnecties
